International Journal of Dermatology · 2018 · 38 citations · 13 references
MedicineClinical SciencesDermatologyAutoimmunityImmunopathologyInflammationImmunopathology Of SkinInflammatory BiomarkersInflammatory DermatosesInflammatory Skin DiseasesInflammatory Skin DisordersC-reactive Protein TestingDisease Severity IndexInflammatory Marker DetectionPsoriatic DiseaseStatistical Significance TestingSystemic Inflammation Markers
BACKGROUND: Psoriasis is a distressing chronic skin disease. Its exact pathogenesis is still unclear, as many factors interplay in its occurrence. AIM: The aim of the study is to estimate elafin levels in the serum of both cases and controls and to correlate the levels with psoriasis severity and other markers of inflammation. SUBJECTS AND METHODS: Twenty-six psoriatic cases along with 26 healthy controls were assigned in this case-control study. Psoriasis severity was determined by Psoriasis Area and Severity Index score. Elafin levels were measured by ELISA in serum of both cases and controls. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured in the cases. RESULTS: Elafin levels show highly statistical significance difference (P < 0.001) between cases and controls. There is a statistical significant correlation between elafin levels and both psoriasis severity and inflammation markers as CRP and ESR. CONCLUSION: Elafin represents a mirror for psoriasis severity and inflammatory state.
13
The inflammatory response in mild and in severe psoriasis
Petronila Rocha‐Pereira, Alice Santos‐Silva, Irene Rebelo et al. · British Journal of Dermatology · 2004 · 259 citations · Full text
Medicine, Dermatology, Immunology +17
Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin
Sophie Paczesny, Thomas Braun, John E. Levine et al. · Science Translational Medicine · 2010 · 246 citations · Full text